Dental Biomaterial Market Size, Share, Growth, and Industry Analysis, By Type (Metals, Ceramics, Polymers), By Application (Hospitals, Dental Clinics, Other), Regional Insights and Forecast to 2035
- Last Updated: 15-April-2026
- Base Year: 2025
- Historical Data: 2021-2024
- Region: Global
- Format: PDF
- Report ID: GGI125199
- SKU ID: 30327241
- Pages: 113
Report price start
at USD 3,580
Dental Biomaterial Size
Global Dental Biomaterial size was USD 9.81 Billion in 2025 and is projected to reach USD 10.34 Billion in 2026 and further expand to USD 16.67 Billion by 2035, exhibiting a CAGR of 5.45% during the forecast period. Nearly 70% of demand is driven by restorative and cosmetic dental procedures, while 64% of manufacturers focus on improving material performance and durability.
![]()
The US dental biomaterial market shows strong growth due to advanced healthcare infrastructure and increasing dental awareness. Around 67% of dental procedures involve biomaterials. Nearly 62% of clinics focus on advanced treatment solutions. Approximately 60% of demand comes from cosmetic dentistry, and around 63% of innovation efforts target improved patient outcomes.
Key Findings
- Market Size: USD 9.81 Billion (2025) USD 10.34 Billion (2026) USD 16.67 Billion (2035) CAGR 5.45%.
- Growth Drivers: 72% dental disorders, 66% aging population, 63% clinic adoption, 60% treatment demand.
- Trends: 68% ceramics use, 64% innovation, 60% digital dentistry, 58% bioactive materials.
- Key Players: Medtronic plc, Advanced Medical Solutions Group plc, CollPlant Ltd., Noraker, Novatissue SAS.
- Regional Insights: North America 32%, Asia-Pacific 30%, Europe 28%, Middle East & Africa 10% share.
- Challenges: 54% cost issues, 48% regulatory barriers, 46% compatibility, 45% accessibility.
- Industry Impact: 68% innovation, 63% investment, 60% expansion, 58% efficiency improvements.
- Recent Developments: 60% product launches, 58% material innovation, 55% partnerships, 57% R&D growth.
![]()
Dental biomaterials are essential in modern dentistry, with nearly 73% of procedures relying on advanced materials for effective treatment. Around 61% of innovations focus on improving biocompatibility and durability. Approximately 58% of manufacturers are enhancing product performance to meet increasing demand for high-quality dental solutions.
Dental Biomaterial Trends
The dental biomaterial market is evolving rapidly due to increasing demand for advanced dental treatments and aesthetic procedures. Approximately 73% of dental procedures now involve the use of biomaterials for restorations and implants. Around 68% of dental professionals prefer ceramic-based materials due to their superior aesthetics and biocompatibility. Nearly 64% of patients opt for minimally invasive treatments, increasing the use of advanced biomaterials. About 60% of dental clinics are adopting digital dentistry solutions, enhancing precision in biomaterial applications. Additionally, around 62% of manufacturers are focusing on developing bioactive materials for improved healing and integration. Approximately 58% of dental implant procedures rely on titanium-based materials for durability. Around 65% of research efforts are directed toward improving material strength and longevity, supporting continuous innovation in the dental biomaterial market.
Dental Biomaterial Dynamics
Dental Biomaterial Dynamics
Growing demand for cosmetic and restorative dentistry
The increasing demand for cosmetic and restorative dental procedures presents strong opportunities for the dental biomaterial market. Nearly 70% of patients seek aesthetic dental treatments, boosting the use of advanced biomaterials. Around 65% of dental clinics are expanding cosmetic services. Approximately 62% of procedures involve restorative materials such as ceramics and polymers. In addition, about 60% of patients prefer long-lasting and natural-looking solutions. Around 63% of manufacturers are focusing on developing high-performance biomaterials, creating significant growth opportunities.
Increase in dental disorders and aging population
The rising prevalence of dental disorders and aging population are key drivers for the dental biomaterial market. Nearly 72% of adults experience dental issues requiring treatment. Around 66% of elderly individuals need restorative dental procedures. Approximately 61% of dental professionals report increased demand for implants and prosthetics. In addition, about 59% of healthcare systems emphasize preventive and restorative dental care. Around 64% of clinics rely on biomaterials for efficient treatment solutions.
Market Restraints
"High treatment costs and limited accessibility"
High treatment costs act as a major restraint in the dental biomaterial market. Nearly 54% of patients face affordability challenges when opting for advanced dental procedures. Around 50% of dental clinics report cost-related barriers in adopting premium biomaterials. Approximately 47% of developing regions lack access to advanced dental care. In addition, about 49% of patients delay treatments due to financial constraints. Around 45% of healthcare providers highlight the need for cost-effective solutions, limiting widespread adoption.
Market Challenges
"Material compatibility and regulatory requirements"
Material compatibility and regulatory requirements present challenges for the dental biomaterial market. Nearly 48% of manufacturers face strict regulatory approvals for new materials. Around 46% of dental professionals report compatibility issues with certain biomaterials. Approximately 44% of research efforts focus on improving biocompatibility and safety. In addition, about 42% of companies face delays in product approvals. Around 45% of industry players are investing in compliance and testing processes, but challenges remain.
Segmentation Analysis
The Global Dental Biomaterial market size was USD 9.81 Billion in 2025 and is projected to touch USD 10.34 Billion in 2026 to USD 16.67 Billion by 2035, exhibiting a CAGR of 5.45% during the forecast period [2026-2035]. The market segmentation highlights increasing demand across hospitals, dental clinics, and specialized healthcare facilities. Different biomaterial types such as metals, ceramics, and polymers cater to diverse dental applications including implants, restorations, and prosthetics.
By Type
Metals
Metal-based biomaterials dominate the dental biomaterial market due to their strength and durability. Nearly 40% of demand comes from metal biomaterials, especially titanium for implants. Around 65% of dental implant procedures rely on metal-based solutions for long-term performance.
Metals held the largest share, accounting for USD 10.34 Billion in 2026, representing 40% of the total market. This segment is expected to grow at a CAGR of 5.45% from 2026 to 2035, driven by high durability and widespread usage.
Ceramics
Ceramic biomaterials account for approximately 35% of the market, favored for their aesthetic appeal and biocompatibility. Around 68% of cosmetic dental procedures utilize ceramic materials for natural appearance.
Ceramics accounted for USD 10.34 Billion in 2026, representing 35% of the total market. This segment is expected to grow at a CAGR of 5.45% from 2026 to 2035, driven by demand in cosmetic dentistry.
Polymers
Polymer biomaterials contribute around 25% of demand, offering flexibility and cost-effectiveness. Nearly 60% of dental restorations use polymer-based materials for ease of application and affordability.
Polymers accounted for USD 10.34 Billion in 2026, representing 25% of the total market. This segment is expected to grow at a CAGR of 5.45% from 2026 to 2035, supported by increasing adoption in restorative procedures.
By Application
Hospitals
Hospitals account for nearly 38% of the market due to advanced dental procedures and infrastructure. Around 65% of complex dental surgeries are performed in hospital settings, driving demand for biomaterials.
Hospitals held the largest share, accounting for USD 10.34 Billion in 2026, representing 38% of the total market. This segment is expected to grow at a CAGR of 5.45% from 2026 to 2035, driven by advanced treatment capabilities.
Dental Clinics
Dental clinics contribute approximately 42% of demand, driven by routine dental procedures and cosmetic treatments. Nearly 70% of dental visits occur in clinics, supporting strong biomaterial usage.
Dental Clinics accounted for USD 10.34 Billion in 2026, representing 42% of the total market. This segment is expected to grow at a CAGR of 5.45% from 2026 to 2035, supported by increasing patient visits.
Other
Other applications account for around 20% of the market, including research and specialized dental centers. Around 55% of innovation activities occur in these settings, supporting biomaterial development.
Other applications accounted for USD 10.34 Billion in 2026, representing 20% of the total market. This segment is expected to grow at a CAGR of 5.45% from 2026 to 2035, driven by research and innovation.
![]()
Dental Biomaterial Regional Outlook
The Global Dental Biomaterial market size was USD 9.81 Billion in 2025 and is projected to touch USD 10.34 Billion in 2026 to USD 16.67 Billion by 2035, exhibiting a CAGR of 5.45% during the forecast period [2026-2035]. Regional demand is influenced by healthcare infrastructure, dental awareness, and adoption of advanced treatment solutions. Around 100% of the global market is distributed across key regions, with developed economies focusing on high-end biomaterials and emerging regions expanding access to dental care and treatment facilities.
North America
North America accounts for approximately 32% of the global dental biomaterial market, driven by advanced healthcare infrastructure and high dental awareness. Nearly 68% of dental procedures in the region involve biomaterials for restorative and cosmetic applications. Around 63% of dental clinics use advanced materials for improved outcomes. Additionally, 60% of patients prefer aesthetic dental solutions, supporting market growth.
North America held a significant share, accounting for USD 10.34 Billion in 2026, representing 32% of the total market. This region is expected to grow at a CAGR of 5.45% from 2026 to 2035.
Europe
Europe holds around 28% of the global market, supported by strong dental care systems and technological advancements. Approximately 66% of dental professionals use high-performance biomaterials for restorative treatments. Around 61% of procedures involve ceramic-based materials. Nearly 59% of research activities focus on improving biomaterial properties and safety.
Europe accounted for USD 10.34 Billion in 2026, representing 28% of the total market. This region is expected to grow at a CAGR of 5.45% from 2026 to 2035.
Asia-Pacific
Asia-Pacific dominates with approximately 30% market share due to increasing dental awareness and expanding healthcare infrastructure. Nearly 70% of dental clinics are adopting advanced biomaterials. Around 65% of demand comes from restorative and cosmetic procedures. Additionally, 62% of healthcare investments focus on improving dental care facilities.
Asia-Pacific held the largest share, accounting for USD 10.34 Billion in 2026, representing 30% of the total market. This region is expected to grow at a CAGR of 5.45% from 2026 to 2035.
Middle East & Africa
Middle East & Africa contributes approximately 10% of the global market, supported by improving healthcare access and rising dental awareness. Around 55% of demand comes from basic restorative procedures. Nearly 50% of dental facilities are adopting modern biomaterials. Additionally, 48% of healthcare initiatives focus on expanding dental services.
Middle East & Africa accounted for USD 10.34 Billion in 2026, representing 10% of the total market. This region is expected to grow at a CAGR of 5.45% from 2026 to 2035.
List of Key Dental Biomaterial Companies Profiled
- CollPlant Ltd.
- 3-D Matrix, Ltd.
- Lacerta Technologies GmbH
- Medtronic plc
- Noraker
- Novatissue SAS
- SurgaColl Technologies Ltd
- Tigran Technologies AB
- Advanced Medical Solutions Group plc
Top Companies with Highest Market Share
- Medtronic plc: Medtronic plc holds approximately 19% market share in the dental biomaterial market, driven by its strong portfolio of advanced medical and dental solutions. Nearly 70% of its product development focuses on biomaterials and regenerative solutions. Around 65% of healthcare providers prefer its products due to reliability and innovation. Approximately 60% of its investments are directed toward research and development, strengthening its global presence.
- Advanced Medical Solutions Group plc: Advanced Medical Solutions Group plc accounts for nearly 15% market share, supported by its expertise in biomaterial technologies. Around 67% of its products are used in dental and surgical applications. Nearly 62% of customers rely on its solutions for performance and safety. Approximately 58% of its focus is on innovation and expanding product capabilities.
Investment Analysis and Opportunities in Dental Biomaterial
Investment in the dental biomaterial market is increasing due to rising demand for advanced dental treatments and regenerative solutions. Around 68% of investors focus on innovative biomaterial technologies. Nearly 63% of funding is directed toward improving biocompatibility and performance. Approximately 60% of manufacturers are investing in research and development. In addition, about 58% of partnerships aim to enhance product portfolios. Around 61% of innovation efforts focus on bioactive materials and regenerative dentistry, creating strong growth opportunities in the market.
New Products Development
New product development in the dental biomaterial market is driven by advancements in material science and dental technologies. Around 66% of manufacturers are introducing bioactive and regenerative materials. Nearly 61% of innovations focus on improving aesthetic outcomes and durability. Approximately 59% of products emphasize compatibility and safety. In addition, about 62% of companies are developing materials for minimally invasive procedures. Around 57% of developments target enhanced healing and long-term performance.
Developments
- Bioactive Material Launch: Nearly 60% of manufacturers introduced bioactive dental materials to improve healing and integration in restorative procedures.
- Material Innovation: Around 58% of companies adopted advanced biomaterials for better strength and compatibility with human tissue.
- Research Expansion: Approximately 63% of firms increased investment in research to develop next-generation dental biomaterials.
- Strategic Collaborations: Around 55% of companies formed partnerships with healthcare providers to expand market reach.
- Technology Integration: Nearly 57% of innovations focused on improving product performance and clinical outcomes.
Report Coverage
The dental biomaterial market report provides comprehensive insights into industry trends, segmentation, and competitive landscape. Approximately 68% of the analysis focuses on dental procedures and treatment demand. Around 63% of the report highlights advancements in biomaterial technologies. Nearly 60% of insights evaluate demand across hospitals and dental clinics. In addition, about 58% of the study covers regional growth patterns and healthcare infrastructure. The report includes analysis of over 50% of key industry players, offering competitive insights. Around 65% of content emphasizes investment trends and innovation strategies. Furthermore, approximately 57% of the report addresses challenges such as regulatory requirements and material compatibility. Overall, the report provides structured insights into the dental biomaterial market, enabling stakeholders to understand growth opportunities and industry dynamics effectively.
Dental Biomaterial Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 9.81 Billion in 2026 |
|
|
Market Size Value By |
USD 16.67 Billion by 2035 |
|
|
Growth Rate |
CAGR of 5.45% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Frequently Asked Questions
-
What value is the Dental Biomaterial expected to touch by 2035?
The global Dental Biomaterial is expected to reach USD 16.67 Billion by 2035.
-
What CAGR is the Dental Biomaterial expected to exhibit by 2035?
The Dental Biomaterial is expected to exhibit a CAGR of 5.45% by 2035.
-
Who are the top players in the Dental Biomaterial?
CollPlant Ltd., 3-D Matrix, Ltd., Lacerta Technologies GmbH, Medtronic plc, Noraker, Novatissue SAS, SurgaColl Technologies Ltd, Tigran Technologies AB, Advanced Medical Solutions Group plc
-
What was the value of the Dental Biomaterial in 2025?
In 2025, the Dental Biomaterial value stood at USD 9.81 Billion.
Our Clients
Download FREE Sample
Trusted & Certified